REMARV Trademark

Trademark Overview

On Friday, March 30, 2012, a trademark application was filed for REMARV with the United States Patent and Trademark Office. The USPTO has given the REMARV trademark a serial number of 85584535. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2015. This trademark is owned by Glaxo Group Limited. The REMARV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
remarv

General Information

Serial Number85584535
Word MarkREMARV
Filing DateFriday, March 30, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 5, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, November 16, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 16, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 24, 2015EXTENSION 5 GRANTED
Thursday, February 12, 2015EXTENSION 5 FILED
Thursday, February 12, 2015TEAS EXTENSION RECEIVED
Wednesday, August 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 26, 2014EXTENSION 4 GRANTED
Friday, August 22, 2014EXTENSION 4 FILED
Friday, August 22, 2014TEAS EXTENSION RECEIVED
Thursday, March 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 5, 2014EXTENSION 3 GRANTED
Tuesday, February 25, 2014EXTENSION 3 FILED
Tuesday, February 25, 2014TEAS EXTENSION RECEIVED
Friday, October 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2013EXTENSION 2 GRANTED
Thursday, August 29, 2013EXTENSION 2 FILED
Thursday, October 3, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 29, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 28, 2013EXTENSION 1 GRANTED
Thursday, February 28, 2013EXTENSION 1 FILED
Thursday, February 28, 2013TEAS EXTENSION RECEIVED
Tuesday, October 16, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 11, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 11, 2012ASSIGNED TO EXAMINER
Thursday, April 5, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 3, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

remarv pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological